Second Primary Differentiated Thyroid Carcinoma in Adult Cancer Survivors: A SEER Database Analysis

甲状腺癌 肿瘤科 医学 内科学 癌症 甲状腺癌 原发性癌症 甲状腺 数据库 计算机科学
作者
Jianhua Feng,Caixiu Wu,Fei Shen,Wen-song Cai,Bo Xu
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [The Endocrine Society]
被引量:1
标识
DOI:10.1210/clinem/dgae501
摘要

Abstract Context Adult cancer survivors are at a heightened risk for secondary primary differentiated thyroid carcinoma (2-DTC). The characteristics and outcomes of 2-DTC remain poorly understood. Objective We aimed to explore the characteristics and outcomes of 2-DTC. Methods We retrospectively analyzed data from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2017). 2-DTC was divided into 25 subgroups based on prior primary malignancies (PPMs). Baseline characteristics were compared using the chi-square test. Multivariable logistic analysis was used to identified if PPMs were associated with aggressive DTC characteristics. DTC-specific and cancer-specific mortality were analyzed using a univariable and multivariable competing risk regression model. Results There were 138 555 1-DTC and 9253 2-DTC patients identified. 2-DTC patients were predominantly older, male, and White compared to first primary DTC (1-DTC) (all P < .05). In multivariable logistic regression analysis, only 4 types of PPMs were associated with higher rates of DTC aggressive characteristics, while 19 types exhibited lower rates (all P < .05). In multivariable competing risk analysis, 2-DTC showed no mortality risk in stages I (SHR: 1.16; 95% CI, 0.65-2.07) and II (SHR: 0.67; 95% CI, 0.45-1.01), but a protective role in stages III (SHR: 0.47; 95% CI, 0.27-0.83) and IV (SHR: 0.72; 95% CI, 0.52-0.99). Most PPMs that developed into 2-DTC had a lower risk of DTC-specific death than 1-DTC, but many PPMs had a higher risk of cancer-specific death. Conclusion Given the characteristics and outcomes of 2-DTC, aggressive treatment for 2-DTC, particularly for PPM with a high mortality risk, may not be advisable.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
心随以动发布了新的文献求助10
1秒前
韩豆乐完成签到,获得积分10
1秒前
深情安青应助韭菜盒子采纳,获得10
3秒前
upupup完成签到 ,获得积分10
10秒前
11秒前
李健应助allen采纳,获得10
11秒前
11秒前
小蘑菇应助Redamancy采纳,获得10
13秒前
在水一方应助YXH采纳,获得10
15秒前
zhangling发布了新的文献求助10
18秒前
星辰大海应助花花采纳,获得10
18秒前
苗条盼芙应助花痴的乐珍采纳,获得10
20秒前
23秒前
23秒前
24秒前
26秒前
隐形曼青应助科研通管家采纳,获得10
26秒前
bkagyin应助科研通管家采纳,获得30
26秒前
Jasper应助科研通管家采纳,获得10
27秒前
顾矜应助科研通管家采纳,获得10
27秒前
大模型应助科研通管家采纳,获得10
27秒前
CodeCraft应助科研通管家采纳,获得10
27秒前
赘婿应助科研通管家采纳,获得10
27秒前
27秒前
Hello应助科研通管家采纳,获得10
27秒前
Ava应助科研通管家采纳,获得10
27秒前
华仔应助科研通管家采纳,获得10
27秒前
27秒前
CodeCraft应助科研通管家采纳,获得10
28秒前
顾矜应助科研通管家采纳,获得10
28秒前
28秒前
28秒前
28秒前
28秒前
30秒前
机灵柚子发布了新的文献求助10
30秒前
自觉千柔关注了科研通微信公众号
31秒前
YXH发布了新的文献求助10
31秒前
落后的初南完成签到,获得积分10
32秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6020282
求助须知:如何正确求助?哪些是违规求助? 7617378
关于积分的说明 16164372
捐赠科研通 5167843
什么是DOI,文献DOI怎么找? 2765864
邀请新用户注册赠送积分活动 1747825
关于科研通互助平台的介绍 1635821